These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18486305)

  • 1. Editorial comment on: Effect of sildenafil on middle-aged sexually active males with no erectile complaints: a randomized placebo-controlled double-blind study.
    Ralph DJ; Garaffa G
    Eur Urol; 2009 Apr; 55(4):978. PubMed ID: 18486305
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: Effect of sildenafil on middle-aged sexually active males with no erectile complaints: a randomized placebo-controlled double-blind study.
    Salonia A
    Eur Urol; 2009 Apr; 55(4):976-7. PubMed ID: 18486319
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: Effect of sildenafil on middle-aged sexually active males with no erectile complaints: a randomized placebo-controlled double-blind study.
    Pescatori ES
    Eur Urol; 2009 Apr; 55(4):977. PubMed ID: 18486316
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of sildenafil on middle-aged sexually active males with no erectile complaints: a randomized placebo-controlled double-blind study.
    Gruenwald I; Leiba R; Vardi Y
    Eur Urol; 2009 Apr; 55(4):969-76. PubMed ID: 18486308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic sildenafil treatment on penile endothelial function: a randomized, double-blind, placebo controlled study.
    Vardi Y; Appel B; Ofer Y; Greunwald I; Dayan L; Jacob G
    J Urol; 2009 Dec; 182(6):2850-5. PubMed ID: 19837434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
    Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
    Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily vardenafil for 6 months has no detrimental effects on semen characteristics or reproductive hormones in men with normal baseline levels.
    Jarvi K; Dula E; Drehobl M; Pryor J; Shapiro J; Seger M
    J Urol; 2008 Mar; 179(3):1060-5. PubMed ID: 18206950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.
    Safarinejad MR; Kolahi AA; Ghaedi G
    BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
    Pickard R
    Eur Urol; 2007 Dec; 52(6):1774-5. PubMed ID: 17478036
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
    Padma-Nathan H; McCullough AR; Levine LA; Lipshultz LI; Siegel R; Montorsi F; Giuliano F; Brock G;
    Int J Impot Res; 2008; 20(5):479-86. PubMed ID: 18650827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study.
    Salonia A
    Eur Urol; 2007 Dec; 52(6):1775-6. PubMed ID: 17478035
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of sildenafil on ocular blood flow.
    Harris A; Kagemann L; Ehrlich R; Ehrlich Y; López CR; Purvin VA
    Br J Ophthalmol; 2008 Apr; 92(4):469-73. PubMed ID: 18369062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled trial of sildenafil in phallometric testing.
    Kolla NJ; Klassen PE; Kuban ME; Blak T; Blanchard R
    J Am Acad Psychiatry Law; 2010; 38(4):502-11. PubMed ID: 21156909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction.
    Burnett AL; Strong TD; Trock BJ; Jin L; Bivalacqua TJ; Musicki B
    J Urol; 2009 Jan; 181(1):245-51. PubMed ID: 19013603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil affects olfactory function.
    Gudziol V; Mück-Weymann M; Seizinger O; Rauh R; Siffert W; Hummel T
    J Urol; 2007 Jan; 177(1):258-61; discussion 261. PubMed ID: 17162058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil reduces postoperative adhesion formation in a rat uterine horn model.
    Batukan C; Ozgun MT; Basbug M; Muderris II
    Eur J Obstet Gynecol Reprod Biol; 2007 Dec; 135(2):183-7. PubMed ID: 16965850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in sperm motility after acute oral administration of sildenafil or tadalafil in young, infertile men.
    Pomara G; Morelli G; Canale D; Turchi P; Caglieresi C; Moschini C; Liguori G; Selli C; Macchia E; Martino E; Francesca F
    Fertil Steril; 2007 Oct; 88(4):860-5. PubMed ID: 17544419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil citrate as a phosphodiesterase inhibitor has an antioxidant effect in the blood of men.
    Perk H; Armagan A; Naziroğlu M; Soyupek S; Hoscan MB; Sütcü R; Ozorak A; Delibas N
    J Clin Pharm Ther; 2008 Dec; 33(6):635-40. PubMed ID: 19138241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are nitrates safe in patients who use sildenafil? Maybe.
    Werns SW
    Crit Care Med; 2007 Aug; 35(8):1988-90. PubMed ID: 17667250
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of sildenafil on heart rate variability in healthy subjects.
    Siepmann M; Rauh R; Dill O; Agelink MW; Mueck-Weymann M
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):598-600. PubMed ID: 18030072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.